Clinical Trial Update: Phase I/II Trial in ES-SCLC to Enhance Response to Atezolizumab Plus Chemotherapy With Total Body Irradiation [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/II clinical trial in extensive-stage small cell lung cancer is evaluating the addition of total body irradiation to atezolizumab plus chemotherapy, an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Extensive Stage Lung Small Cell Carcinoma, Stage IV Lung Cancer | Phase 1, Phase 2 | Status: RECRUITING